Q1 2025 saw strong Animal Care sales growth and global expansion, while Human Care focused on clinical trials. Losses narrowed, but additional funding is needed for continued operations.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.